MAPK3 and diffuse large B-cell lymphoma: Specifically, diffuse large B-cell lymphoma cells treated with Pterostilbene at concentrations ≥50 μM showed reduced growth and viability, with cell death induced through the inhibition of ERK1/2 and the activation of the p38MAPK signaling pathways [77].